Advertisement

Infection

, Volume 47, Issue 1, pp 135–136 | Cite as

Malassezia in the central nervous system and multiple sclerosis

  • Julián Benito-LeónEmail author
  • Martin Laurence
Correspondence
  • 108 Downloads

Notes

Compliance with ethical standards

Conflict of interest

We declare no competing interests.

References

  1. 1.
    Góralska K, Blaszkowska J, Dzikowiec M. Neuroinfections caused by fungi. Infection. 2018;46(4):443–59.  https://doi.org/10.1007/s15010-018-1152-2.CrossRefGoogle Scholar
  2. 2.
    Laurence M, Asquith M, Rosenbaum JT. Spondyloarthritis, acute anterior Uveitis and fungi: updating the Catterall King hypothesis. Front Med. 2018.  https://doi.org/10.3389/fmed.2018.00080.Google Scholar
  3. 3.
    Benito-León J, Pisa D, Alonso R, Calleja P, Díaz-Sánchez M, Carrasco L. Association between multiple sclerosis and Candida species: evidence from a case-control study. Eur J Clin Microbiol Infect Dis. 2010;29(9):1139–45.  https://doi.org/10.1007/s10096-010-0979-y.CrossRefGoogle Scholar
  4. 4.
    Benito-León J, Laurence M. The role of fungi in the etiology of multiple sclerosis. Front Neurol. 2017;8:535.  https://doi.org/10.3389/fneur.2017.00535.CrossRefGoogle Scholar
  5. 5.
    Olar A, Shafi R, Gilger M, Stager C, Moss J, Schady D, et al. Central nervous system involvement by Malassezia restricta, an unusual fungal pathogen: a report of two cases. Neurology. 2012;78(1 Supplement):P01.245.Google Scholar
  6. 6.
    Alonso R, Pisa D, Marina AI, Morato E, Rábano A, Carrasco L. Fungal infection in patients with Alzheimer’s disease. J Alzheimer’s Dis. 2014;41(1):301–11.  https://doi.org/10.3233/JAD-132681.CrossRefGoogle Scholar
  7. 7.
    Alonso R, Fernández-Fernández AM, Pisa D, Carrasco L. Multiple sclerosis and mixed microbial infections. Direct identification of fungi and bacteria in nervous tissue. Neurobiol Dis. 2018;117:42–61.  https://doi.org/10.1016/j.nbd.2018.05.022.CrossRefGoogle Scholar
  8. 8.
    Samuel S, Loftus E Jr, Sandborn W. The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis. Aliment Pharmacol Ther. 2010;32(9):1207–9.  https://doi.org/10.1111/j.1365-2036.2010.04444.x.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of NeurologyUniversity Hospital “12 de Octubre”CosladaSpain
  2. 2.Department of Medicine, Faculty of MedicineComplutense UniversityMadridSpain
  3. 3.Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)MadridSpain
  4. 4.Shipshaw LabsMontrealCanada

Personalised recommendations